QCM
SUPN icon

Quantinno Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Quantinno Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Buy
26,209
+1,818
+7% +$92.6K ﹤0.01% 1920
2025
Q4 		$1.21M Buy
24,391
+3,525
+17% +$171K ﹤0.01% 1651
2025
Q3 		$997K Buy
20,866
+6,193
+42% +$249K ﹤0.01% 1499
2025
Q2 		$462K Buy
14,673
+4,302
+41% +$138K ﹤0.01% 1703
2025
Q1 		$340K Buy
10,371
+1,970
+23% +$69.8K ﹤0.01% 1565
2024
Q4 		$304K Buy
8,401
+864
+11% +$30.4K ﹤0.01% 1382
2024
Q3 		$235K Sell
7,537
-68
-0.9% -$2.12K ﹤0.01% 1340
2024
Q2 		$203K Buy
7,605
+835
+12% +$24.2K ﹤0.01% 1262
2024
Q1 		$231K Buy
+6,770
New +$202K 0.01% 1148
2023
Q2 		– Sell
-6,305
Closed -$228K – 948
2023
Q1 		$228K Hold
6,305
– – 0.02% 790
2022
Q4 		$225K Sell
6,305
-14
-0.2% -$487 0.02% 757
2022
Q3 		$214K Buy
+6,319
New +$206K 0.03% 561
2021
Q4 		– Sell
-10,188
Closed -$272K – 548
2021
Q3 		$272K Hold
10,188
– – 0.3% 164
2021
Q2 		$314K Hold
10,188
– – 0.36% 144
2021
Q1 		$267K Sell
10,188
-10,119
-50% -$283K 0.29% 188
2020
Q4 		$511K Sell
20,307
-6,732
-25% -$145K 0.4% 73
2020
Q3 		$563K Buy
+27,039
New +$614K 0.38% 71
2020
Q2 		– Sell
-35,663
Closed -$642K – 448
2020
Q1 		$642K Buy
+35,663
New +$749K 0.4% 60
2019
Q4 		– Sell
-14,482
Closed -$398K – 492
2019
Q3 		$398K Buy
+14,482
New +$429K 0.27% 167

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantinno Capital Management's SUPN Position: Q1 2026 in Review

Quantinno Capital Management increased its Supernus Pharmaceuticals (SUPN) stake by 7.5% in Q1 2026, buying an estimated $92.6K and bringing the position to 26,209 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1920.

Quantinno Capital Management first reported a position in SUPN in Q3 2019 and has held it in 19 quarters since. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Quantinno Capital Management held 26,209 shares of Supernus Pharmaceuticals worth $1.35M as of Q1 2026.
  • Quantinno Capital Management bought 1,818 Supernus Pharmaceuticals shares in Q1 2026, an estimated $92.6K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #1920 holding.
  • Quantinno Capital Management first reported a position in Supernus Pharmaceuticals in Q3 2019 and has held it in 19 quarters since.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.